Johnson & Johnson (J&J) has agreed to pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its talc-based baby powder and other products caused ovarian cancer. The pharmaceutical giant announced the proposed settlement to bring an end to over a decade of protracted litigation, even as it continues to deny any wrongdoing.
Settlement Details and Company Stance
The proposed agreement covers approximately 76,000 existing claims across federal and state courts in the United States. For the settlement to become final, at least 95% of the ovarian cancer claimants must accept the terms. J&J has consistently maintained that its talc products are safe, do not contain asbestos, and do not cause cancer.
"While we are confident the company would have ultimately prevailed with further litigation, as it has in the vast majority of cases tried to date, this resolution allows the company to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives," stated Erik Haas, J&J's vice president of litigation.
The company views the settlement as a strategic move to achieve closure and move past the extensive legal battle.
A Decade of Litigation
This agreement follows more than ten years of legal challenges, numerous trials, appeals, and three unsuccessful attempts by J&J to use bankruptcy proceedings to manage the litigation. Plaintiffs' law firms confirmed the deal, describing it as a fair resolution given the lengthy court fight.
Payment Structure and Potential for Higher Payouts
J&J anticipates paying $3 billion in 2027, with additional payments scheduled for 2028. The total value of the settlement could increase depending on the final number of claimants who opt into the agreement. Chris Seeger, a lawyer representing roughly 2,500 clients with talc claims and a key negotiator in the agreement, suggested that J&J's total payout could ultimately reach $7 billion or more, as the settlement assigns specific values to qualifying ovarian cancer claims without capping the company’s total liability.
Product Changes and Previous Settlements
The lawsuits primarily alleged that women developed ovarian cancer after prolonged use of Johnson & Johnson’s talc-based baby powder. Many plaintiffs also claimed the talc contained asbestos. In response to the mounting legal pressure and evolving market demands, J&J ceased selling talc-based baby powder in the U.S. and Canada in 2020, transitioning to a cornstarch-based alternative. The company had previously settled most cases specifically alleging that its talc contained asbestos and caused mesothelioma.